Valganciclovir Rowex 450 mg film coated tablet Ireland - English - HPRA (Health Products Regulatory Authority)

valganciclovir rowex 450 mg film coated tablet

rowex ltd - valganciclovir hydrochloride - film-coated tablet - 450 milligram(s) - nucleosides and nucleotides excl. reverse transcriptase inhibitors; valganciclovir

Valganciclovir 450mg Film-coated Tablets United Kingdom - English - myHealthbox

valganciclovir 450mg film-coated tablets

milpharm limited - valganciclovir - film-coated tablets - 450mg - antivirals for systemic use, nucleosides and nucleotides excl. reverse transcriptase inhibitors - it is indicated for the induction and maintenance treatment of cytomegalovirus (cmv) retinitis in adult patients with acquired immunodeficiency syndrome (aids) and for the prevention of cmv disease in cmvnegative adults and children (aged from birth to 18 years) who have received a solid organ transplant from a cmv-positive donor.

Valganciclovir 450mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

valganciclovir 450mg tablets

a a h pharmaceuticals ltd - valganciclovir hydrochloride - oral tablet - 450mg

Valganciclovir 450mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

valganciclovir 450mg tablets

mawdsley-brooks & company ltd - valganciclovir hydrochloride - oral tablet - 450mg

NAT-VALGANCICLOVIR TABLET Canada - English - Health Canada

nat-valganciclovir tablet

natco pharma (canada) inc - valganciclovir (valganciclovir hydrochloride) - tablet - 450mg - valganciclovir (valganciclovir hydrochloride) 450mg - nucleosides and nucleotides

Valganciclovir 450mg Film-coated Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

valganciclovir 450mg film-coated tablets

generics (uk) limited - valganciclovir - film-coated tablet - 450 milligram(s) - nucleosides and nucleotides excl. reverse transcriptase inhibitors; valganciclovir